SCHEMBL8563398

SCHEMBL8563398

CCCc1c(OCCCOc2cc(O)c(-c3ccc(F)cc3)cc2CC)cccc1Oc1ccccc1CC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 20/20 1.00
LTB4R2 Q9NPC1 19/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Etalocib SCHEMBL29379752 0.89 LTB4R (1.00) LTB4RLTB4R2
Etalocib SCHEMBL1649516 0.89 LTB4R (1.00) LTB4RLTB4R2
Etalocib SCHEMBL6356831 0.88 LTB4R (0.98) LTB4RLTB4R2
Etalocib SCHEMBL4306319 0.88 LTB4R (0.98) LTB4RLTB4R2
SCHEMBL6898153 0.87 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL13696754 0.87 LTB4R (0.86) LTB4RLTB4R2
SCHEMBL6899046 0.86 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7624513 0.86 LTB4R (0.84) LTB4RLTB4R2
Etalocib SCHEMBL4306317 0.85 LTB4R (0.83) LTB4RLTB4R2
SCHEMBL6897565 0.85 LTB4R (1.00) LTB4RLTB4R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0544488-B1 Substituted phenyl phenol leukotriene antagonists LILLY CO ELI (US) 1998-03-11 EP disclosed
WO-1996036347-A1 USE OF LEUKOTRIENE ANTAGONISTS FOR ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1996-11-21 WO disclosed
EP-0743064-A1 Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease ELI LILLY AND COMPANY (US) 1996-11-20 EP disclosed
US-5462954-A Antiinflammatory, antiallergens; treating asthma ELI LILLY AND COMPANY (US) 1995-10-31 US disclosed
EP-0544488-A2 Substituted phenyl phenol leukotriene antagonists ELI LILLY AND COMPANY (US) 1993-06-02 EP disclosed